With escalating returns, subsiding risks and anticipated multifold growth, the Indian pharmaceutical industry is on the verge of becoming an attractive investment destination, fascinating investors from around the globe. But lately, the concern over food and drug safety has engendered an alarm about good manufacturing practices (GMP). Hence, there is a need for tests and other methods to assure that basic materials, equipment and manufacturing techniques are working as intended to create safe, high quality end products.

One solution to this muddle lies in the usage of superior ingredients and advanced testing solutions. Integrating the supply of quality ingredients with technical know-how is Lonza. Founded in 1897 in the Swiss Alps, Lonza today has more than 40 manufacturing and R&D sites around the world, including in Hyderabad. The company’s Specialty Ingredients and Pharma & Biotech segments provide innovative solutions and custom manufacturing and development services to customers, including many facing intense regulatory scrutiny. In particular, the company possesses a rich experience of 40 years in providing endotoxin detection products and services, which are vital to assuring product quality and patient safety.

Lonza has core strengths in innovation, technology, and regulatory expertise as well as cross-divisional synergies in manufacturing, research and sales. Further, the company helps customers address intense regulatory reviews with comprehensive QC Microbiology programs for validating secure processing areas to assure they are free of contamination. The company acknowledges the significance of software inaccurate analysis and reporting and thus has its own in-house development systems and programmers, dedicated to producing robust software solutions.

Initiating Paperless Technology with MODA™ Solution and WinKQCL™ Software Integration
Lonza offers paperless Microbiology EM documentation, an automated quality solution, through its MODA™ & WinKQCL™ Software Solutions.

Brijesh Gupta, Business Director, Lonza Bioscience Solutions, India, emphasizes that, “MODA™ Software improves compliance by combining automated scheduling, workflows, mobile data acquisition, device integration, and advanced analytics, while WinKQCL™ 5 Software provides a cohesive solution for quantitative endotoxin detection testing, data management and reporting needs.” WinKQCL™ Software, Lonza’s most advanced endotoxin detection and analysis software, proffers a fully-integrated solution for quantitative endotoxin detection testing, data management and reporting needs.

“Both MODA™ & WinKQCL™ softwares meet 21 CFR Part 11 technical requirements for electronic records and signatures, audit trails and database archiving,” says Brijesh. MODA™ Solution, an amalgam of specialized hardware, software and implementation services, is designed to adopt quickly, granting time and resources to be directed towards higher- value initiatives and paths to operational excellence.

The company recently launched a new online platform -- the QC Insider™ Toolbox -- to support the Pharma & Biotech industry with education, references and contacts for assistance related to endotoxin testing assays and software. Lonza is committed to helping clients assure product safety and efficacy with its innovative toolbox of products and services to detect contamination issues, helping customers avoid the potentially devastating consequences that come with a loss of brand confidence.